NYSE:ABBVBiotechs
AbbVie (ABBV) Stock May Trade Above Fair Value Following Its 157% Run
AbbVie stock has delivered a strong 156.7% total return over the past five years. However, there is a clear split in what the valuation tools indicate today. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while traditional market multiples make the shares look expensive, and the overall value score remains low.
Over five years, AbbVie has returned 156.7%, which puts extra focus on whether current buyers are paying too much for that track record.
Progress...